Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protein-protein interaction surfaces refer to the regions on proteins that mediate direct physical contacts between protein molecules, allowing for the formation of multi-protein assemblies crucial for cellular functions such as signaling, structural organization, regulation, and catalysis[1][3]. These surfaces are characterized by specific arrangements of amino acids that provide shape and chemical complementarity for binding; forces such as hydrophobic interactions, hydrogen bonding, van der Waals interactions, and electrostatic forces commonly stabilize these interfaces[6][7]. The biological consequence of PPIs depends on the proteins involved, with roles in virtually all aspects of biology, health, and disease. Modulating PPIs has become a major focus in drug discovery, but targeting these surfaces poses unique structural and pharmacological challenges due to their often large and featureless nature[8][5].
Inhibition of protein–protein association, Stabilization of protein complexes, Allosteric modulation of interacting partners
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein-protein interaction surface (PPI surface).